Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / American Depositary Shares, each representing one ordinary share
-
Shares outstanding
-
40,291,821
-
Total 13F shares
-
3,987,438
-
Share change
-
+3,987,438
-
Total reported value
-
$66,015,000
-
Price per share
-
$16.78
-
Number of holders
-
18
-
Value change
-
+$66,015,000
-
Number of buys
-
18
Institutional Holders of Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS) as of Q2 2021
As of 30 Jun 2021,
Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,987,438 shares.
The largest 10 holders included
Alphabet Inc., M&G INVESTMENT MANAGEMENT LTD, Tudor Investment Corp Et Al, Hudson Bay Capital Management LP, Monashee Investment Management LLC, MILLENNIUM MANAGEMENT LLC, CAAS CAPITAL MANAGEMENT LP, BlackRock Inc., Ipswich Investment Management Co., Inc., and Vontobel Holding Ltd..
This page lists
18
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.